CORRELATED INTERACTIONS OF DYSLIPID AND DISHORMONAL DISORDERS IN PATIENTS WITH HYPOTHYROIDISM
DOI:
https://doi.org/10.11603/1811-2471.2022.v.i4.13510Keywords:
hypothyroidism, lipidogram, thyroid-stimulating hormone, free thyroxine, atherosclerosisAbstract
SUMMARY. The problem of the development of atherosclerosis as one of the basic pathogenetic syndromes in any nosology, including with hypothyroidism (HT) is an extremely urgent problem, especially since the data of scientific sources testify to contradictory results regarding the parameters of the lipid profile in this category of patients.
The aim – to investigate the parameters of the lipid profile of patients with HT and their dependence on the levels of thyroid hormones.
Material and Methods. 44 ambulatory HT patients aged 26 to 69 were examined. All patients underwent a general clinical examination of the patient; determination of the thyroid profile (thyroid-stimulating hormone (TSH) and free thyroxine (fT4) levels). Violations of lipid status were assessed by the level of total cholesterol (CHL), triglycerides (TG), low-density lipoprotein (LDL), very low-density lipoprotein (LDL), high-density lipoprotein (HDL), and the atherogenic factor (AF).
Results. The assessment of the above indicators indicates the presence of pathological changes in lipid metabolism in 72.73 % of the group of patients with HT. HDL as an anti-atherogenic blood factor was significantly reduced in HT patients compared to the control group. It was found that the level of TG was significantly higher by 0.6 mmol/L (31.09 %), CKD was higher by 2.54 mmol/L (67.5 %), and the level of LDL prevailed by 1.68 mmol/L (75.67 %) in the group of patients with HT than in the control group (р<0.05); AF was three times higher in the group of HT patients compared to the control group (p<0.001). According to lipidogram data, hyperlipoproteinemia of type IIa (14 patients – 31.82 %) and IIb types (18 patients – 40.91 %) was found in patients on HT.
Conclusions. Based on the correlation-regression analysis, a reliable dependence of the levels of HC, TG, LDL, LDL, AF, HDL was established (respectively r=0.67, r=0.69, r=0.64, r=0.69, r =0.72, r=-0.52; (р<0.05)) from the levels of thyroid-stimulating hormone, as well as free thyroxine (respectively r=-0.55, r=-0.49, r=-0, 54, r=-0.49, r=-0.59, r=0.52; (р<0.05). The obtained results prove that a decrease in the content of thyroid hormones in blood serum during HT is a predictor of lipid metabolism disorders towards atherosclerosis .
References
Vasylenko, O.A., & Sencha, I.A. (2012). Matematychno-statystychni metody analizu v prykladnykh doslidzhennyakh [Mathematical and statistical methods of analysis in applied research] [in Ukrainian].
Bodnar, P.M. (2013). Endokrynolohiya : pidruchnyk dlya studentiv vyshchykh med. navch. zakladiv [Endocrinology. Textbook for medical students of higher education institutions]. Vinnytsia: Nova knyha [in Ukrainian].
Lyashuk, P.M., Lyashuk, R.P., & Shkhodnytskyi, I.V. (2020). Deyaki dyskusiyni pytannya problemy hipotyreozu [Some debatable issues of the problem of hypothyroidism]. Klinichna ta eksperymentalna patolohiya - Clinical and Experimental Pathology, 19(4), 102-106 [in Ukrainian].
Mitchenko, O.I., & Lutai, M.I. (2007). Dyslipidemiyi: diahnostyka, profilaktyka ta likuvannya [Dyslipidemias: diagnosis, prevention and treatment]. Kyiv: Chetverta khvylia [in Ukrainian].
Christian, N., Rhodes, M.A., Adams, C.S., & Bragg, S. (2022). Thyroid and Parathyroid Conditions: Hypothyroidism. FP Essent, 514, 18-23. PMID: 35235282.
Chaker, L., Bianco, A.C., Jonklaas, J., & Peeters, R.P. (2017). Hypothyroidism. Lancet, 390(10101), 1550-1562. DOI: 10.1016/S0140-6736(17)30703-1. Epub 2017 Mar. 20. PMID: 28336049; PMCID: PMC6619426.
Davis, M.G., & Phillippi, J.C. (2022). Hypothyroidism: Diagnosis and Evidence-Based Treatment. J. Midwifery Womens Health, 67(3), 394-397. DOI: 10.1111/jmwh.13358. Epub 2022 Apr. 5. PMID: 35384263.
Fredrickson, D.S., & Lees, R.S. (1965) A system for phenotyping hyperlipoproteinemia. Circulation, 31, 321-327.
Garmendia Madariaga, A., Santos Palacios, S., Guillén-Grima, F., & Galofré, J.C. (2014). The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J. Clin. Endocrinol. Metab., 99(3), 923-931. DOI: 10.1210/jc.2013-2409. Epub 2014 Jan 1. PMID: 24423323.
(2022). Hypothyroidism. Nat. Rev. Dis. Primers, 8(1), 31. DOI: 10.1038/s41572-022-00364-8. PMID: 35589732.
Garber, J.R., Cobin, R.H., & Gharib, H. (2012). Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine Practice, 18(6), 988-1028 DOI: 10.4158/EP12280.GL Epub 2012 Nov. 01.
Taylor, P.N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J.H., Dayan, C.M., & Okosieme, O.E. (2018). Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol., 14(5), 301-316. DOI: 10.1038/nrendo.2018.18. Epub 2018 Mar. 23. PMID: 29569622.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Achievements of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.